Changing face of β2-adrenergic and muscarinic receptor therapies in asthma

Current Opinion in Pharmacology

Volumn 16, Issue 1, 2014, Pages 148-156

  Wasilewski, Nastasia V ^a   Lougheed, M Diane ^a   Fisher, John T ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FENOTEROL; FORMOTEROL; IPRATROPIUM BROMIDE; LONG ACTING DRUG; MUSCARINIC RECEPTOR; PLACEBO; RESPIMAT; SALBUTAMOL; SALMETEROL; SHORT ACTING DRUG; TIOTROPIUM BROMIDE; UNCLASSIFIED DRUG;

ADD ON THERAPY; AIRWAY REMODELING; ASTHMA; BRONCHODILATATION; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRY POWDER INHALER; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; REVIEW; SOFT MIST INHALER; TACHYPHYLAXIS; UNSPECIFIED SIDE EFFECT; ANIMAL; PATHOLOGY; PATHOPHYSIOLOGY;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; AIRWAY REMODELING; ANIMALS; ASTHMA; CHOLINERGIC ANTAGONISTS; HUMANS;

EID: 84902160266     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2014.05.007     Document Type: Review

References (88)

1. M.D. Lougheed, C. Lemiere, F.M. Ducharme, C. Licskai, S.D. Dell, B.H. Rowe, M. Fitzgerald, R. Leigh, W. Watson, and L.P. Boulet Canadian thoracic society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults Can Respir J 19 2012 127 164
2. S. Turner, J. Paton, B. Higgins, and G. Douglas British guidelines on the management of asthma: what's new for 2011? Thorax 66 2011 1104 1105
3. E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, and S.E. Pedersen et al. Global strategy for asthma management and prevention: Gina executive summary Eur Respir J 31 2008 143 178
4. Expert panel report 3 (epr-3) Guidelines for the diagnosis and management of asthma-summary report 2007 J Allergy Clin Immunol 120 5 Suppl 2007 S94 S138
5. J. Crane, N. Pearce, A. Flatt, C. Burgess, R. Jackson, T. Kwong, M. Ball, and R. Beasley Prescribed fenoterol and death from asthma in new zealand, 1981-83: case-control study Lancet 1 1989 917 922 (Pubitemid 19126879)
6. N. Pearce, R. Beasley, J. Crane, C. Burgess, and R. Jackson End of the New Zealand asthma mortality epidemic Lancet 345 1995 41 44
7. W.O. Spitzer, S. Suissa, P. Ernst, R.I. Horwitz, B. Habbick, D. Cockcroft, J.F. Boivin, M. McNutt, A.S. Buist, and A.S. Rebuck The use of beta-agonists and the risk of death and near death from asthma N Engl J Med 326 1992 501 506
8. R.A. Pauwels, C.G. Lofdahl, D.S. Postma, A.E. Tattersfield, P. O'Byrne, P.J. Barnes, and A. Ullman Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and corticosteroids establishing therapy (facet) international study group N Engl J Med 337 1997 1405 1411
9. P.M. O'Byrne, P.J. Barnes, R. Rodriguez-Roisin, E. Runnerstrom, T. Sandstrom, K. Svensson, and A. Tattersfield Low dose inhaled budesonide and formoterol in mild persistent asthma: the optima randomized trial Am J Respir Crit Care Med 164 8 Pt 1 2001 1392 1397 (Pubitemid 33124016)
10. H.S. Nelson, S.T. Weiss, E.R. Bleecker, S.W. Yancey, and P.M. Dorinsky The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol Chest 129 2006 15 26 (Pubitemid 43265239)
11. J.M. Kramer Balancing the benefits and risks of inhaled long-acting beta-agonists - the influence of values N Engl J Med 360 2009 1592 1595
12. B.A. Chowdhury, and G. Dal Pan The fda and safe use of long-acting beta-agonists in the treatment of asthma N Engl J Med 362 2010 1169 1171
13. M.D. Lougheed, C. Lemiere, S. Dell, F. Ducharme, J.M. Fitzgerald, R. Leigh, C. Licskai, B.H. Rowe, D. Bowie, A. Becker, and L.P. Boulet Canadian thoracic society asthma committee commentary on long-acting beta-2 agonist use for asthma in Canada Can Respir J 17 2010 57 60
14. B.J. Lipworth Long-acting beta2-adrenoceptor agonists: a smart choice for asthma? Trends Pharmacol Sci 28 2007 257 262 (Pubitemid 46830815)
15. B.J. Lipworth, and I. Aziz A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol J Allergy Clin Immunol 103 1 Pt 1 1999 88 92 (Pubitemid 29063196)
16. D.K. Lee, C.M. Jackson, G.P. Currie, W.J. Cockburn, and B.J. Lipworth Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma Br J Clin Pharmacol 56 2003 494 500 (Pubitemid 37386502)
17. R.A. McIvor, E. Pizzichini, M.O. Turner, P. Hussack, F.E. Hargreave, and M.R. Sears Potential masking effects of salmeterol on airway inflammation in asthma Am J Respir Crit Care Med 158 1998 924 930 (Pubitemid 28449462)
18. S.R. Salpeter, N.S. Buckley, T.M. Ormiston, and E.E. Salpeter Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths Ann Internal Med 144 2006 904 912 (Pubitemid 46768131)
19. S.R. Salpeter, A.J. Wall, and N.S. Buckley Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events Am J Med 123 2010 322-328 e322
20. J.K. Walker, R.B. Penn, N.A. Hanania, B.F. Dickey, and R.A. Bond New perspectives regarding beta(2)-adrenoceptor ligands in the treatment of asthma Br J Pharmacol 163 2011 18 28
21. V.J. Thanawala, G.S. Forkuo, N. Al-Sawalha, Z. Azzegagh, L.P. Nguyen, J.L. Eriksen, M.J. Tuvim, T.W. Lowder, B.F. Dickey, B.J. Knoll, and J.K. Walker et al. Beta2-adrenoceptor agonists are required for development of the asthma phenotype in a murine model Am J Respir Cell Mol Biol 48 2013 220 229
22. P.M. Short, P.A. Williamson, W.J. Anderson, and B.J. Lipworth Randomized placebo-controlled trial to evaluate chronic dosing effects of propranolol in asthma Am J Respir Crit Care Med 187 2013 1308 1314
23. R.A. Bond The intrinsic bias of generalizations Am J Respir Crit Care Med 189 2014 359
24. B.J. Canning, and A. Fischer Neural regulation of airway smooth muscle tone Respir Physiol 125 2001 113 127 (Pubitemid 32184648)
25. K.S. Buels, and A.D. Fryer Muscarinic receptor antagonists: effects on pulmonary function Handb Exper Pharmacol 208 2012 317 341
26. J.T. Fisher, S.G. Vincent, J. Gomeza, M. Yamada, and J. Wess Loss of vagally mediated bradycardia and bronchoconstriction in mice lacking m2 or m3 muscarinic acetylcholine receptors FASEB J 18 2004 711 713
27. G.D. Scott, and A.D. Fryer Role of parasympathetic nerves and muscarinic receptors in allergy and asthma Chem Immunol Allergy 98 2012 48 69
28. N.A. Molfino, A.S. Slutsky, G. Julia-Serda, V. Hoffstein, J.P. Szalai, K.R. Chapman, A.S. Rebuck, and N. Zamel Assessment of airway tone in asthma. Comparison between double lung transplant patients and healthy subjects Am Rev Respir Dis 148 1993 1238 1243 (Pubitemid 23326020)
29. B.J. O'Connor, L.J. Towse, and P.J. Barnes Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma Am J Respir Crit Care Med 154 4 Pt 1 1996 876 880
30. D.P. Tashkin Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety Curr Opin Pulm Med 16 2010 97 105
31. N.J. Gross Anticholinergic agents in asthma and copd Eur J Pharmacol 533 2006 36 39 (Pubitemid 43340003)
32. M.D. Lougheed, C. Lemiere, S.D. Dell, F.M. Ducharme, J.M. Fitzgerald, R. Leigh, C. Licskai, B.H. Rowe, D. Bowie, A. Becker, and L.P. Boulet Canadian thoracic society asthma management continuum - 2010 consensus summary for children six years of age and over, and adults Can Respir J 17 2010 15 24
33. M. Westby, M. Benson, and P. Gibson Anticholinergic agents for chronic asthma in adults Cochrane Database Syst Rev 3 2004 CD003269
34. N.J. McDonald, and A.I. Bara Anticholinergic therapy for chronic asthma in children over two years of age Cochrane Database Syst Rev 3 2003 CD003535
35. K. Richter, S. Stenglein, M. Mucke, C. Sieder, S. Schmidtmann, U. Harnest, G. Weidinger, and H. Magnussen Onset and duration of action of formoterol and tiotropium in patients with moderate to severe copd Respir Int Rev Thoracic Dis 73 2006 414 419
36. K.M. Beeh, and J. Beier The short, the long and the "ultra- long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease Adv Therapy 27 2010 150 159
37. J.F. Donohue Therapeutic responses in asthma and copd. Bronchodilators Chest 126 2 Suppl 2004 125S 137S discussion 159S-161S (Pubitemid 39093402)
38. R. Hodder, M.D. Lougheed, J.M. FitzGerald, B.H. Rowe, A.G. Kaplan, and R.A. McIvor Management of acute asthma in adults in the emergency department: assisted ventilation CMAJ: Can Med Assoc J 182 2010 265 272
39. T. Delbridge, R. Domeier, and C.B. Key Prehospital asthma management Prehospital Emergency Care 7 2003 42 47 (Pubitemid 36091796)
40. L.H. Plotnick, and F.M. Ducharme Should inhaled anticholinergics be added to beta2 agonists for treating acute childhood and adolescent asthma? A systematic review BMJ 317 1998 971 977 (Pubitemid 28457256)
41. F. Qureshi, J. Pestian, P. Davis, and A. Zaritsky Effect of nebulized ipratropium on the hospitalization rates of children with asthma N Engl J Med 339 1998 1030 1035 (Pubitemid 28457864)
42. G.J. Rodrigo, and J.A. Castro-Rodriguez Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis Thorax 60 2005 740 746 (Pubitemid 41297893)
43. D.E. O'Donnell, S. Aaron, J. Bourbeau, P. Hernandez, D.D. Marciniuk, M. Balter, G. Ford, A. Gervais, R. Goldstein, and R. Hodder et al. Canadian thoracic society recommendations for management of chronic obstructive pulmonary disease - 2007 update Can Respir J 14 Suppl B 2007 5B 32B (Pubitemid 350090390)
44. J. Vestbo, S.S. Hurd, A.G. Agusti, P.W. Jones, C. Vogelmeier, A. Anzueto, P.J. Barnes, L.M. Fabbri, F.J. Martinez, and M. Nishimura et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: gold executive summary Am J Respir Crit Care Med 187 2013 347 365
45. B. Celli, M. Decramer, S. Kesten, D. Liu, S. Mehra, and D.P. Tashkin Mortality in the 4-year trial of tiotropium (uplift) in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 180 2009 948 955
46. Y. Tang, D. Massey, and N.S. Zhong Evaluation of the efficacy and safety of tiotropium bromide (5 microg) inhaled via respimat in Chinese patients with chronic obstructive pulmonary disease Chin Med J 126 2013 3603 3607
47. P. Casarosa, T. Bouyssou, S. Germeyer, A. Schnapp, F. Gantner, and M. Pieper Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs J Pharmacol Exp Therap 330 2009 660 668
48. P. Casarosa, T. Kiechle, P. Sieger, M. Pieper, and F. Gantner The constitutive activity of the human muscarinic m3 receptor unmasks differences in the pharmacology of anticholinergics J Pharmacol Exp Therap 333 2010 201 209
49. S. Singh, Y.K. Loke, and C.D. Furberg Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis JAMA 300 2008 1439 1450
50. P. Anderson Use of respimat soft mist inhaler in copd patients Int J Chronic Obstructive Pulmonary Disease 1 2006 251 259
51. S. Singh, Y.K. Loke, P.L. Enright, and C.D. Furberg Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials BMJ 342 2011 d3215
52. C. Karner, J. Chong, and P. Poole Tiotropium versus placebo for chronic obstructive pulmonary disease Cochrane Datab Syst Rev 7 2012 CD009285
53. R. Beasley, S. Singh, Y.K. Loke, P. Enright, and C.D. Furberg Call for worldwide withdrawal of tiotropium respimat mist inhaler BMJ 345 2012 e7390
54. R.A. Wise, A. Anzueto, P. Calverley, R. Dahl, D. Dusser, G. Pledger, M. Koenen-Bergmann, E. Joseph, D. Cotton, and B. Disse The tiotropium safety and performance in respimat trial (tiospir), a large scale, randomized, controlled, parallel-group trial-design and rationale Respir Res 14 2013 40
55. R.A. Wise, A. Anzueto, D. Cotton, R. Dahl, T. Devins, B. Disse, D. Dusser, E. Joseph, S. Kattenbeck, and M. Koenen-Bergmann et al. Tiotropium respimat inhaler and the risk of death in copd N Engl J Med 369 2013 1491 1501
56. C.R. Jenkins More than just reassurance on tiotropium safety N Engl J Med 369 2013 1555 1556
57. C.R. Jenkins Tiotropium and the risk of death in copd N Engl J Med 370 2014 482 483
58. K.M. Verhamme, N. van Blijderveen, and M.C. Sturkenboom Tiotropium and the risk of death in copd N Engl J Med 370 2014 481 482
59. Y.K. Loke, S. Singh, and C.D. Furberg Tiotropium and the risk of death in copd N Engl J Med 370 2014 480 481
60. R.A. Wise Tiotropium and the risk of death in copd N Engl J Med 370 2014 482
61. S.P. Peters, S.J. Kunselman, N. Icitovic, W.C. Moore, R. Pascual, B.T. Ameredes, H.A. Boushey, W.J. Calhoun, M. Castro, and R.M. Cherniack et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma N Engl J Med 363 2010 1715 1726
62. E.D. Bateman, O. Kornmann, P. Schmidt, A. Pivovarova, M. Engel, and L.M. Fabbri Tiotropium is noninferior to salmeterol in maintaining improved lung function in b16-arg/arg patients with asthma J Allergy Clin Immunol 128 2011 315 322
63. H.A. Kerstjens, B. Disse, W. Schroder-Babo, T.A. Bantje, M. Gahlemann, R. Sigmund, M. Engel, and J.A. van Noord Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial J Allergy Clin Immunol 128 2011 308 314
64. H.A. Kerstjens, M. Engel, R. Dahl, P. Paggiaro, E. Beck, M. Vandewalker, R. Sigmund, W. Seibold, P. Moroni-Zentgraf, and E.D. Bateman Tiotropium in asthma poorly controlled with standard combination therapy N Engl J Med 367 2012 1198 1207
65. J.A. Elias, Z. Zhu, G. Chupp, and R.J. Homer Airway remodeling in asthma J Clin Investig 104 1999 1001 1006
66. N. Carroll, J. Elliot, A. Morton, and A. James The structure of large and small airways in nonfatal and fatal asthma Am Rev Respir Dis 147 1993 405 410 (Pubitemid 23044915)
67. T. Aikawa, S. Shimura, H. Sasaki, M. Ebina, and T. Takishima Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack Chest 101 1992 916 921
68. W.R. Roche, R. Beasley, J.H. Williams, and S.T. Holgate Subepithelial fibrosis in the bronchi of asthmatics Lancet 1 1989 520 524 (Pubitemid 19075206)
69. J.A. Elias, C.G. Lee, T. Zheng, B. Ma, R.J. Homer, and Z. Zhu New insights into the pathogenesis of asthma J Clin Investig 111 2003 291 297 (Pubitemid 36182201)
70. B.R. Wiggs, R. Moreno, J.C. Hogg, C. Hilliam, and P.D. Pare A model of the mechanics of airway narrowing J Appl Physiol (1985) 69 1990 849 860 (Pubitemid 20338681)
71. J.A. Nadel, and K. Takeyama Mechanisms of hypersecretion in acute asthma, proposed cause of death, and novel therapy Pediatric Pulmonol Suppl 18 1999 54 55 (Pubitemid 29140306)
72. D.F. Rogers Airway mucus hypersecretion in asthma: an undervalued pathology? Curr Opin Pharmacol 4 2004 241 250 (Pubitemid 38585308)
73. R.M. Pascual, and S.P. Peters The irreversible component of persistent asthma J Allergy Clin Immunol 124 2009 883 890 quiz 891-882
74. K. Yamauchi Airway remodeling in asthma and its influence on clinical pathophysiology The Tohoku journal of experimental medicine 209 2006 75 87
75. D. Bumbacea, D. Campbell, L. Nguyen, D. Carr, P.J. Barnes, D. Robinson, and K.F. Chung Parameters associated with persistent airflow obstruction in chronic severe asthma Eur Respir J 24 2004 122 128 (Pubitemid 39029077)
76. M.A. Swartz, D.J. Tschumperlin, R.D. Kamm, and J.M. Drazen Mechanical stress is communicated between different cell types to elicit matrix remodeling Proc Natl Acad Sci U S A 98 2001 6180 6185 (Pubitemid 32488213)
77. D.J. Tschumperlin, and J.M. Drazen Chronic effects of mechanical force on airways Annu Rev Physiol 68 2006 563 583
78. X. Trepat, L. Deng, S.S. An, D. Navajas, D.J. Tschumperlin, W.T. Gerthoffer, J.P. Butler, and J.J. Fredberg Universal physical responses to stretch in the living cell Nature 447 2007 592 595 (Pubitemid 46868039)
79. D.J. Tschumperlin, G. Dai, I.V. Maly, T. Kikuchi, L.H. Laiho, A.K. McVittie, K.J. Haley, C.M. Lilly, P.T. So, and D.A. Lauffenburger et al. Mechanotransduction through growth-factor shedding into the extracellular space Nature 429 2004 83 86 (Pubitemid 38620555)
80. C.L. Grainge, L.C. Lau, J.A. Ward, V. Dulay, G. Lahiff, S. Wilson, S. Holgate, D.E. Davies, and P.H. Howarth Effect of bronchoconstriction on airway remodeling in asthma N Engl J Med 364 2011 2006 2015
81. T.A. Oenema, H. Maarsingh, M. Smit, G.M. Groothuis, H. Meurs, and R. Gosens Bronchoconstriction induces tgf-beta release and airway remodelling in guinea pig lung slices PloS One 8 2013 e65580
82. I.S. Bos, R. Gosens, A.B. Zuidhof, D. Schaafsma, A.J. Halayko, H. Meurs, and J. Zaagsma Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison Eur Resp J 30 2007 653 661 (Pubitemid 351194824)
83. T. Pera, A. Zuidhof, J. Valadas, M. Smit, R.G. Schoemaker, R. Gosens, H. Maarsingh, J. Zaagsma, and H. Meurs Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of copd Eur Respir J 38 2011 789 796
84. S. Ohta, N. Oda, T. Yokoe, A. Tanaka, Y. Yamamoto, Y. Watanabe, K. Minoguchi, T. Ohnishi, T. Hirose, H. Nagase, and K. Ohta et al. Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma Clin Exp Allergy 40 2010 1266 1275
85. J.Y. Kang, C.K. Rhee, J.S. Kim, C.K. Park, S.J. Kim, S.H. Lee, H.K. Yoon, S.S. Kwon, Y.K. Kim, and S.Y. Lee Effect of tiotropium bromide on airway remodeling in a chronic asthma model Anna Allergy, Asthma Immunol 109 2012 29 35
86. L.E. Kistemaker, S.T. Bos, W.M. Mudde, M.N. Hylkema, P.S. Hiemstra, J. Wess, H. Meurs, H.A. Kerstjens, and R. Gosens Muscarinic m3 receptors contribute to allergen-induced airway remodeling in mice Am J Respir Cell Mol Biol 50 2014 690 698
87. K. Nakajima, and J. Wess Design and functional characterization of a novel, arrestin-biased designer g protein-coupled receptor Mol Pharmacol 82 2012 575 582
88. S.P. Peters, E.R. Bleecker, S.J. Kunselman, N. Icitovic, W.C. Moore, R. Pascual, B.T. Ameredes, H.A. Boushey, W.J. Calhoun, and M. Castro et al. Predictors of response to tiotropium versus salmeterol in asthmatic adults J Allergy Clin Immunol 132 2013 1068-1074 e1061.